11 results
424B4
BGLC
BioNexus Gene Lab Corp
21 Jul 23
Prospectus supplement with pricing info
3:37pm
retrial on the merits. The rights of shareholders to take legal action against us and BioNexus’ directors, actions by minority shareholders
10-K
1ts4p3slnf1t6ed
31 Mar 20
Annual report
1:12pm
S-1/A
nd5rbn26rh3d2 df1
25 Feb 19
IPO registration (amended)
3:30pm
S-1
fp6 6k2w3m3a
29 Jan 19
IPO registration
12:00am
- Prev
- 1
- Next